Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Mulder

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 6, 2008
Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometryR ter Heine, H Rosing, E C M van Gorp, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluidD M Burger, H Rosing, C H ten Napel, et al.
AIDS (London, England)|September 1, 1989
Appearance of predictors of disease progression in relation to the development of AIDSF de Wolf, J M Lange, J T Houweling, et al.
AIDS (London, England)|November 1, 1992
HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatmentC A Boucher, J M Lange, F F Miedema, et al.
AIDS (London, England)|October 8, 1999
The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individualsR P van Heeswijk, A I Veldkamp, R M Hoetelmans, et al.
Blood|August 1, 1993
Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridizationR E Kibbelaar, J W Mulder, E J Dreef, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 27, 2009
Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometryR ter Heine, M Davids, H Rosing, et al.
Antiviral Research|March 1, 1990
Long-term zidovudine treatment of asymptomatic HIV-1-infected subjectsJ W Mulder, F de Wolf, J Goudsmit, et al.
AIDS (London, England)|March 14, 2000
Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavirC H Koks, R P van Heeswijk, A I Veldkamp, et al.
Antiviral Therapy|February 22, 2000
Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapyD M Burger, R M Hoetelmans, P W Hugen, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 6, 2008
Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometryR ter Heine, H Rosing, E C M van Gorp, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluidD M Burger, H Rosing, C H ten Napel, et al.
AIDS (London, England)|September 1, 1989
Appearance of predictors of disease progression in relation to the development of AIDSF de Wolf, J M Lange, J T Houweling, et al.
AIDS (London, England)|November 1, 1992
HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatmentC A Boucher, J M Lange, F F Miedema, et al.
AIDS (London, England)|October 8, 1999
The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individualsR P van Heeswijk, A I Veldkamp, R M Hoetelmans, et al.
Blood|August 1, 1993
Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridizationR E Kibbelaar, J W Mulder, E J Dreef, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 27, 2009
Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometryR ter Heine, M Davids, H Rosing, et al.
Antiviral Research|March 1, 1990
Long-term zidovudine treatment of asymptomatic HIV-1-infected subjectsJ W Mulder, F de Wolf, J Goudsmit, et al.
AIDS (London, England)|March 14, 2000
Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavirC H Koks, R P van Heeswijk, A I Veldkamp, et al.
Antiviral Therapy|February 22, 2000
Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapyD M Burger, R M Hoetelmans, P W Hugen, et al.
Pageof 15